Intellipharmaceutics Announces Third Quarter 2014 Results
Stockhouse The Company recorded a net loss for the three months ended August 31, 2014 of $1.7 million, or $0.07 per common share, compared with a net loss of $2.0 million, or $0.10 per common share for the three months ended August 31, 2013. The Company … For … |